These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2546299)

  • 1. The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation.
    de Gast GC; Gratama JW; Verdonck LF; van Heugten JG; Zwaan FE; Phillips DI; Mudde GC
    Transplantation; 1989 Jul; 48(1):111-5. PubMed ID: 2546299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.
    Williamson SA; Parish N; Chambers JD; Knight RA
    Immunology; 1986 Mar; 57(3):437-42. PubMed ID: 3007334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase.
    Ljungman P; Wahren B; Sundqvist VA
    J Virol Methods; 1985 Dec; 12(3-4):199-208. PubMed ID: 2422193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
    Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
    J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.
    Boström L; Ringdén O; Forsgren M
    Scand J Immunol; 1991 Jul; 34(1):45-52. PubMed ID: 1648786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
    Ljungman P; Wilczek H; Gahrton G; Gustavsson A; Lundgren G; Lönnqvist B; Ringdén O; Wahren B
    Bone Marrow Transplant; 1986 Dec; 1(2):185-92. PubMed ID: 2844333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral serology after bone marrow transplantation.
    Epstein JB; Phillips K; Sherlock CH
    Viral Immunol; 1991; 4(2):133-7. PubMed ID: 1662045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.
    Sundin M; Orvell C; Rasmusson I; Sundberg B; Ringdén O; Le Blanc K
    Bone Marrow Transplant; 2006 Jun; 37(11):1051-9. PubMed ID: 16604097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.
    Grob JP; Grundy JE; Prentice HG; Griffiths PD; Hoffbrand AV; Hughes MD; Tate T; Wimperis JZ; Brenner MK
    Lancet; 1987 Apr; 1(8536):774-6. PubMed ID: 2882184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibody profile against herpesviruses in renal transplant recipients.
    Carpi C; Donati M; Musiani M; Zerbini M; Cevenini R; Feletti C
    Boll Ist Sieroter Milan; 1982; 61(3):245-7. PubMed ID: 6100358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early recovery of lymphocyte response to Candida after bone marrow transplantation in colonized patients.
    Tollemar J; Ringdén O
    Bone Marrow Transplant; 1991 Apr; 7(4):285-91. PubMed ID: 2070134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients.
    Lolli F; Sundqvist VA; Castagna A; Ljungman P; Linde A; Andersson G; Olsson T; Wahren B
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):55-62. PubMed ID: 8395936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation.
    Gratama JW; Verdonck LF; van der Linden JA; van Heugten JG; Kreeft HA; D'Amaro J; Zwaan FE; de Gast GC
    Transplantation; 1986 Jun; 41(6):719-24. PubMed ID: 3012833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regeneration of humoral immunity to herpes simplex virus following T-cell-depleted allogeneic bone marrow transplantation.
    Wimperis JZ; Berry NJ; Prentice HG; Lever A; Griffiths PD; Brenner MK
    J Med Virol; 1987 Sep; 23(1):93-9. PubMed ID: 2824679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
    Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.